Teva Pharmaceutical Industries Ltd. (TEVA)
39.10
-0.03
(-0.08%)
USD |
NYSE |
Oct 07, 11:36
Teva Pharmaceutical Industries Market Cap : 45.55B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 45.59B |
| October 05, 2026 | 46.20B |
| October 02, 2026 | 46.05B |
| October 01, 2026 | 45.80B |
| September 30, 2026 | 46.13B |
| September 29, 2026 | 46.38B |
| September 28, 2026 | 45.30B |
| September 25, 2026 | 45.66B |
| September 24, 2026 | 46.86B |
| September 23, 2026 | 45.45B |
| September 22, 2026 | 46.04B |
| September 21, 2026 | 46.67B |
| September 18, 2026 | 45.41B |
| September 17, 2026 | 45.66B |
| September 16, 2026 | 44.89B |
| September 15, 2026 | 45.73B |
| September 14, 2026 | 45.11B |
| September 11, 2026 | 43.10B |
| September 10, 2026 | 42.35B |
| September 09, 2026 | 42.93B |
| September 08, 2026 | 42.83B |
| September 04, 2026 | 42.36B |
| September 03, 2026 | 42.66B |
| September 02, 2026 | 43.68B |
| September 01, 2026 | 42.16B |
| Date | Value |
|---|---|
| August 31, 2026 | 42.00B |
| August 28, 2026 | 42.45B |
| August 27, 2026 | 43.83B |
| August 26, 2026 | 44.18B |
| August 25, 2026 | 44.39B |
| August 24, 2026 | 43.02B |
| August 21, 2026 | 43.50B |
| August 20, 2026 | 42.88B |
| August 19, 2026 | 43.65B |
| August 18, 2026 | 42.62B |
| August 17, 2026 | 42.48B |
| August 14, 2026 | 42.84B |
| August 13, 2026 | 42.55B |
| August 12, 2026 | 42.80B |
| August 11, 2026 | 42.50B |
| August 10, 2026 | 42.10B |
| August 07, 2026 | 41.19B |
| August 06, 2026 | 40.55B |
| August 05, 2026 | 40.45B |
| August 04, 2026 | 40.11B |
| August 03, 2026 | 40.15B |
| July 31, 2026 | 40.79B |
| July 30, 2026 | 41.25B |
| July 29, 2026 | 40.44B |
| July 28, 2026 | 36.90B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.132T |
| Bristol Myers Squibb Co. | 122.51B |
| Merck & Co., Inc. | 354.67B |
| RedHill Biopharma Ltd. | 2.433M |
| Johnson & Johnson | 626.81B |
Market Cap Related Metrics
| PE Ratio | 65.75 |
| PS Ratio | 2.622 |
| Price to Book Value | 5.875 |
| Price to Free Cash Flow | 31.16 |
| Price | 39.10 |
| Earnings Yield | 1.52% |
| Operating PE Ratio | 13.96 |
| Normalized PE Ratio | 24.63 |